| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 7e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |